Search research articles
Contact Us
Filters
Showing results (21-30 of 102) with videos related to
Page
of 11
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association
|
February 15, 2023
Disease-free survival as a predictor of overall survival in localized renal cell carcinoma following initial nephrectomy: A retrospective analysis of Surveillance, Epidemiology and End Results-Medicare datac
Naomi B Haas, Yan Song, Jaqueline Willemann Rogerio, et al.
Urology
|
September 28, 2011
Prostate-specific antigen surveillance among men with clinically localized prostate cancer who do not receive initial treatment
Debra Nana Yeboa, Thomas Guzzo, Nandita Mitra, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 18, 2016
Phase 1 Trial of Everolimus and Radiation Therapy for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy
Vivek Narayan, Neha Vapiwala, Rosemarie Mick, et al.
Medical Oncology (Northwood, London, England)
|
February 8, 2011
A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802
Naomi B Haas, Xinyi Lin, Judith Manola, et al.
The Oncologist
|
April 4, 2022
ADXS31142 Immunotherapy ± Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 Study
Mark N Stein, Lawrence Fong, Ronald Tutrone, et al.
Diabetes Care
|
February 6, 2014
Incidence of bladder cancer in patients with type 2 diabetes treated with metformin or sulfonylureas
Ronac Mamtani, Nick Pfanzelter, Kevin Haynes, et al.
JAMA Oncology
|
March 10, 2017
Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the ASSURE Randomized Trial
Naomi B Haas, Judith Manola, Janice P Dutcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2021
Novel Redirected T-Cell Immunotherapies for Advanced Prostate Cancer
Tanya B Dorff, Vivek Narayan, Stephen J Forman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2018
Pazopanib Exposure Relationship with Clinical Efficacy and Safety in the Adjuvant Treatment of Advanced Renal Cell Carcinoma
Cora N Sternberg, Frede Donskov, Naomi B Haas, et al.
Journal of Managed Care & Specialty Pharmacy
|
September 1, 2022
Clinical and economic burdens of recurrence following nephrectomy for intermediate high- or high-risk renal cell carcinoma: A retrospective analysis of Surveillance, Epidemiology, and End Results-Medicare data
Murali Sundaram, Yan Song, Jaqueline Willemann Rogerio, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 102) with videos related to
Sort By:
Page
of 11
International Journal of Urology : Official Journal of the Japanese Urological Association
|
February 15, 2023
Disease-free survival as a predictor of overall survival in localized renal cell carcinoma following initial nephrectomy: A retrospective analysis of Surveillance, Epidemiology and End Results-Medicare datac
Naomi B Haas, Yan Song, Jaqueline Willemann Rogerio, et al.
Urology
|
September 28, 2011
Prostate-specific antigen surveillance among men with clinically localized prostate cancer who do not receive initial treatment
Debra Nana Yeboa, Thomas Guzzo, Nandita Mitra, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 18, 2016
Phase 1 Trial of Everolimus and Radiation Therapy for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy
Vivek Narayan, Neha Vapiwala, Rosemarie Mick, et al.
Medical Oncology (Northwood, London, England)
|
February 8, 2011
A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802
Naomi B Haas, Xinyi Lin, Judith Manola, et al.
The Oncologist
|
April 4, 2022
ADXS31142 Immunotherapy ± Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 Study
Mark N Stein, Lawrence Fong, Ronald Tutrone, et al.
Diabetes Care
|
February 6, 2014
Incidence of bladder cancer in patients with type 2 diabetes treated with metformin or sulfonylureas
Ronac Mamtani, Nick Pfanzelter, Kevin Haynes, et al.
JAMA Oncology
|
March 10, 2017
Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the ASSURE Randomized Trial
Naomi B Haas, Judith Manola, Janice P Dutcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2021
Novel Redirected T-Cell Immunotherapies for Advanced Prostate Cancer
Tanya B Dorff, Vivek Narayan, Stephen J Forman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2018
Pazopanib Exposure Relationship with Clinical Efficacy and Safety in the Adjuvant Treatment of Advanced Renal Cell Carcinoma
Cora N Sternberg, Frede Donskov, Naomi B Haas, et al.
Journal of Managed Care & Specialty Pharmacy
|
September 1, 2022
Clinical and economic burdens of recurrence following nephrectomy for intermediate high- or high-risk renal cell carcinoma: A retrospective analysis of Surveillance, Epidemiology, and End Results-Medicare data
Murali Sundaram, Yan Song, Jaqueline Willemann Rogerio, et al.
Page
of 11